Allergic asthma
Conditions
Interventions
Jiaji points group:Electroacupuncture at C7-T3 jiaji points combined with basic drug therapy.
Non-meridian non-acupoint group:Electroacupuncture at non-meridian non-acupoints combined with basic drug therapy.
Sponsors
Shanxi Provincial Hospital of Acupuncture and Moxibustion
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for allergic asthma (based on the Global Initiative for Asthma (GINA, 2023) and the diagnostic criteria for allergic asthma recorded in the "Chinese Guidelines for the Diagnosis and Treatment of Allergic Asthma (First Edition, 2019)" edited by the Respiratory Allergy Working Group (under preparation) of the Chinese Medical Association's Allergy Branch and the Asthma Working Group of the Chinese Medical Association's Respiratory Disease Branch, as well as the "Guidelines for the Prevention and Treatment of Bronchial Asthma" (2020 edition) edited by the Asthma Working Group of the Chinese Medical Association's Respiratory Disease Branch); (2) Meets the criteria for mild to moderate chronic persistent asthma; (3) No restrictions on gender, age between 18 and 65 years, good mental status, able to cooperate with treatment and examinations; (4) Has not participated in other clinical studies in the past month; (5) Has been living in the local area for a long time; (6) Voluntarily agrees and signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with a confirmed history of respiratory system diseases affecting lung function, including pneumonia, tuberculosis, lung abscess, and other pulmonary infectious diseases; bronchiectasis, chronic bronchitis, chronic obstructive pulmonary disease (COPD), and other airway diseases; (2) individuals with incomplete case records; (3) patients with mental disorders; (4) individuals with implanted pacemakers; (5) those with severe cardiovascular, cerebrovascular, immune system diseases, or malignant tumors; (6) individuals who have participated in another clinical trial or received treatment for respiratory system diseases within the past 4 weeks; (7) individuals with contagious skin diseases or skin damage in the treatment area; (8) pregnant women, breastfeeding women, or those suspected of being pregnant; (9) individuals with a fear of needles or a history of fainting due to needles.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma Control Test Form; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulmonary Function Test;Asthma Quality of Life Questionnaire;IL-8;IL-4;IL-5;IL-13;TNF-a;IgE; | — |
Countries
China
Contacts
Public ContactJi Laixi
Shanxi Provincial Hospital of Acupuncture and Moxibustion
Outcome results
None listed